Terms: = Leukemia AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Prognosis
7 results:
1. [Clinical Analysis of Driver Mutations in Patients with Ph Negative Myeloproliferative Neoplasms].
He ZP; Tian HY; Tan M; Wu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):842-848. PubMed ID: 29950230
[TBL] [Abstract] [Full Text] [Related]
2. Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study.
Frederiksen H; Farkas DK; Christiansen CF; Larsen TS; Hasselbalch HC; Stentoft J; Sørensen HT
Lancet Haematol; 2015 Jul; 2(7):e289-96. PubMed ID: 26688384
[TBL] [Abstract] [Full Text] [Related]
3. Rates of complete diagnostic testing for patients with acute myeloid leukemia.
Lin TL; Williams T; He J; Aljitawi OS; Ganguly S; Abhyankar S; Fleming A; Male H; McGuirk JP
Cancer Med; 2015 Apr; 4(4):519-22. PubMed ID: 25620650
[TBL] [Abstract] [Full Text] [Related]
4. The development and application of imatinib.
Jones RL; Judson IR
Expert Opin Drug Saf; 2005 Mar; 4(2):183-91. PubMed ID: 15794712
[TBL] [Abstract] [Full Text] [Related]
5. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans.
Maki RG; Awan RA; Dixon RH; Jhanwar S; Antonescu CR
Int J Cancer; 2002 Aug; 100(6):623-6. PubMed ID: 12209598
[TBL] [Abstract] [Full Text] [Related]
6. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia.
Raimondi SC; Pui CH; Hancock ML; Behm FG; Filatov L; Rivera GK
Leukemia; 1996 Feb; 10(2):213-24. PubMed ID: 8637229
[TBL] [Abstract] [Full Text] [Related]
7. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
[TBL] [Abstract] [Full Text] [Related]
